The invention relates to the field of
protein detection, in particular to a method for detecting phosphorylated Tau-217
protein in
urine of an Alzheimer's
disease patient, which comprises the following steps of: 1, collecting fresh
urine in the
morning by using a
urine collecting container, and 2, taking out 100 microliters of urine by using a transfer
pipette and adding the urine into a 5.0 ml centrifugal tube; step 3, adding 4.9 ml of a urine
diluent to dilute the urine; and step 4, prefabricating tracing
fluorescent microspheres and enrichment microspheres in the centrifugal tube. Step 5, repeatedly reversing and uniformly mixing, and reacting at
room temperature for 8-12 hours; step 5, placing the
reaction tube on a separation
test tube rack with a
magnet for more than 20 minutes; step 6, irradiating the
test tube by using a highlighter with the
wavelength of about 340nm in a dark environment to judge a result; and step 7, if a red fluorescent dot appears near the
magnet in the
test tube, the result is positive, otherwise, the result is negative, and the result can also be judged by measuring a
fluorescence value through a luminoscope with the
wavelength of 340nm. Finally, the phosphorylated Tau-217
protein is detected, and the operation threshold and the economic cost are reduced.